Indirect Treatment Comparisons of Ibrutinib Versus Physician’s Choice and Idelalisib Plus Ofatumumab in Patients With Previously Treated Chronic Lymphocytic Leukemia

Autor: Sorensen, Sonja, Wildgust, Mark, Sengupta, Nishan, Trambitas, Cristina, Diels, Joris, van Sanden, Suzy, Xu, Yingxin, Dorman, Emily
Zdroj: In Clinical Therapeutics January 2017 39(1):178-189
Databáze: ScienceDirect